Tag: Windlas Biotech IPO Analysis
Search
Subscribe to Blog via Email
About Suresh KP
Hello, this is Suresh KP, the founder of this blog. I have written over 2,500 articles on this blog covering various investment options in India. I am a Certified Investment Adviser and a Certified Research Analyst. However, I am NOT a SEBI Registered Investment Advisor. The articles on this blog are created for educational purposes only. Please consult your investment adviser before making any investment decisions.
Top Posts & Pages
- 10 Debt Mutual Funds Outperformed in Last 1 Year with 10% to 24% Returns in 2025
- 10 Mutual Funds That Crashed the Most in the Last 1 Year (-14% to -16%)
- Vikran Engineering IPO GMP, Listing Gains Potential and Valuation Analysis
- 12 Mutual Funds Outperformed in Last 2 Years with 75% to 118% Returns
- Anlon Healthcare IPO - Review, Date, Price, GMP, Analysis – Should You Subscribe or Avoid?
- 10 Mutual Funds Outperformed in Last 1 Year with 37% to 82% Returns
- Vikran Engineering IPO Review – Date, Price, GMP, Analysis – Should you Subscribe or Avoid?
- Anlon Healthcare IPO Subscription Status, GMP and Listing Expectations
- Best Mutual Funds to Invest in 2025 When Interest Rates Are Falling
- Vikran Engineering IPO – Key Strengths, Risks, and Long-Term Prospects Investors Should Know
Category of Articles
- Classroom Lessons (187)
- Crorepathi Ideas (26)
- Fixed Income (393)
- Insurance Plans (268)
- IPOs (271)
- Money Saving Ideas (41)
- Mutual Funds (525)
- NCDs (132)
- New Fund Offers (NFO) (138)
- Other-Ideas (260)
- Retirement Planning (55)
- Small Business Ideas (79)
- Stocks (389)
- Taxation (136)